Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies

Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease

(2015) Luisa Strocchio et al.   BRITISH JOURNAL OF HAEMATOLOGY

Health-Related Quality of Life in Adolescents with Thalassemia

(2015) Nonglak Boonchooduang et al.   PEDIATRIC HEMATOLOGY AND ONCOLOGY

Silent cerebral infarction, income, and grade retention among students with sickle cell anemia

(2014) Allison A. King et al.   AMERICAN JOURNAL OF HEMATOLOGY

Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease

(2014) M Bhatia et al.   BONE MARROW TRANSPLANTATION

Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Phenotype

(2014) Matthew M. Hsieh et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mixed chimerism in haemoglobinopathies: from risk of graft rejection to immune tolerance

(2014) M. Andreani et al.   TISSUE ANTIGENS

Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia

(2013) Michael J. Eckrich et al.   AMERICAN JOURNAL OF HEMATOLOGY

Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling

(2013) F. Locatelli et al.   BLOOD

Stem cell transplantation after reduced-intensity conditioning for sickle cell disease

(2013) Susanne Matthes-Martin et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts

(2013) Vikram Mathews et al.   PLoS One

Unrelated Donor Cord Blood Transplantation for Children with Severe Sickle Cell Disease: Results of One Cohort from the Phase II Study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN)

(2012) Naynesh R. Kamani et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

French Multicenter 22-Year Experience in Stem Cell Transplantation for Beta-Thalassemia Major: Lessons and Future Directions

(2012) Claire Galambrun et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The relationship between the severity of hemolysis, clinical manifestations and risk of death in 415 patients with sickle cell anemia in the US and Europe

(2012) M. Nouraie et al.   HAEMATOLOGICA

Umbilical Cord Blood Transplantation for Children with Thalassemia and Sickle Cell Disease

(2011) Annalisa Ruggeri et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allogeneic hematopoietic stem cell transplantation for sickle cell disease: the time is now

(2011) M. M. Hsieh et al.   BLOOD

Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patients

(2011) T-H Jaing et al.   BONE MARROW TRANSPLANTATION

Population Estimates of Sickle Cell Disease in the U.S.

(2010) Kathryn L. Hassell   AMERICAN JOURNAL OF PREVENTIVE MEDICINE

HLA-matched sibling bone marrow transplantation for  -thalassemia major

(2010) M. Sabloff et al.   BLOOD

Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease

(2010) M E McPherson et al.   BONE MARROW TRANSPLANTATION

Pulmonary, Gonadal, and Central Nervous System Status after Bone Marrow Transplantation for Sickle Cell Disease

(2009) Mark C. Walters et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Stable Long-Term Donor Engraftment following Reduced-Intensity Hematopoietic Cell Transplantation for Sickle Cell Disease

(2008) Lakshmanan Krishnamurti et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Advances in the allogeneic transplantation for thalassemia

(2007) Guido Lucarelli et al.   BLOOD REVIEWS